On April 1, 2026, China implemented a landmark national standard: Classification and Determination of TCM Constitution. Although designated as a recommended rather than mandatory standard, it represents a major step in modernizing traditional Chinese medicine (TCM) by converting traditional constitution theory into a clear, measurable and clinically practical framework. By clarifying the relationship between constitution, disease, and pattern differentiation, the standard strengthens professional credibility, supports research, and enhances patient-centered treatment.
Sarah Li, PhD
Dr. Sarah Li is the founder of Wei Laboratories, Inc. (www.weilab.com), which offers a full range of Chinese herbal products with compressive training and services. Representative products include FASTT Patch and WHITEE Patch that address many tough-to-treat musculoskeletal conditions. Dr. Li attended the University of Science and Technology of China, majoring in biology and graduating with the highest honor as the valedictorian; and completed her PhD in Biochemistry at the University of Minnesota, Twin Cities. Dr. Li accomplished her research fellowship at Beth Israel Hospital, focusing on the pathogenesis of type II diabetes. She also worked as a research associate at Harvard Medical School.